H U : Notice Regarding Revision of Dividend Forecast (Commemorative Dividend)
May 19, 2021 at 05:02 am
Share
May 14, 2021
FOR IMMEDIATE RELEASE
Company name:
H.U. Group Holdings, Inc.
Representative:
Shigekazu Takeuchi, Director,
President and Group CEO
Securities code:
4544 First Section, Tokyo Stock
Contact:
Exchange
Naoki Kitamura, CFO
Telephone No:
03-5909-3337
Notice Regarding Revision of Dividend Forecast (Commemorative Dividend)
H.U. Group Holdings, Inc. (hereinafter, "the Company") hereby announces that it has revised its year-end dividend forecast for the fiscal year ended March 31, 2021, as stated in the "Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (under Japanese GAAP)" released today. Details are as follows.
The subject matter will officially be determined by resolution of the Board of Directors at a meeting scheduled to be held on May 21, 2021.
1. Reason for revision of dividend forecast
As stated in the "Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (under Japanese GAAP)" released today, the financial results for the fiscal year ended March 31, 2021 have been finalized and the Company decided to pay an ordinary dividend of 75 yen per share, which had previously been undecided. Moreover, in commemorating the 70th anniversary of its foundation, the Company will also pay a commemorative dividend of 19 yen per share, in order to express gratitude to its shareholders for their constant support.
As a result, the year-end dividend for the fiscal year ended March 31, 2021 will be 94 yen per share and the annual total dividend for the fiscal year will be 144 yen per share, with the interim dividend paid of 50 yen.
2. Details of revision
Dividend per share (yen)
Record date
Interim
Year-end
Annual
Previous forecast
TBD
TBD
Current forecast
94.00 yen
144.00 yen
Ordinary dividend: 75 yen
Ordinary dividend: 125 yen
Commemorative dividend: 19 yen
Commemorative dividend: 19 yen
Actual results of the
50.00 yen
fiscal year ended
March 31, 2021
Actual results of the
65.00 yen
65.00 yen
130.00 yen
fiscal year ended
March 31, 2020
End
Attachments
Original document
Permalink
Disclaimer
Miraca Holdings Inc. published this content on 19 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 May 2021 04:01:01 UTC.
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.